Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:354671.
doi: 10.1155/2015/354671. Epub 2015 May 19.

Metabolomics for Biomarker Discovery: Moving to the Clinic

Aihua Zhang  1 , Hui Sun  1 , Guangli Yan  1 , Ping Wang  1 , Xijun Wang  1
Affiliations
Review

Metabolomics for Biomarker Discovery: Moving to the Clinic

Aihua Zhang et al. Biomed Res Int. 2015.

Abstract

To improve the clinical course of diseases, more accurate diagnostic and assessment methods are required as early as possible. In order to achieve this, metabolomics offers new opportunities for biomarker discovery in complex diseases and may provide pathological understanding of diseases beyond traditional technologies. It is the systematic analysis of low-molecular-weight metabolites in biological samples and has become an important tool in clinical research and the diagnosis of human disease and has been applied to discovery and identification of the perturbed pathways. It provides a powerful approach to discover biomarkers in biological systems and offers a holistic approach with the promise to clinically enhance diagnostics. When carried out properly, it could provide insight into the understanding of the underlying mechanisms of diseases, help to identify patients at risk of disease, and predict the response to specific treatments. Currently, metabolomics has become an important tool in clinical research and the diagnosis of human disease and becomes a hot topic. This review will highlight the importance and benefit of metabolomics for identifying biomarkers that accurately screen potential biomarkers of diseases.

PubMed Disclaimer

References

    1. Tomita M., Kami K. Systems biology, metabolomics, and cancer metabolism. Science. 2012;336(6084):990–991. doi: 10.1126/science.1223066. - DOI - PubMed
    1. Zhang A., Sun H., Wang X. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment. Applied Biochemistry and Biotechnology. 2012;168(6):1718–1727. doi: 10.1007/s12010-012-9891-5. - DOI - PubMed
    1. Tsutsui H., Maeda T., Min J. Z., et al. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry. Clinica Chimica Acta. 2011;412(11-12):861–872. doi: 10.1016/j.cca.2010.12.023. - DOI - PubMed
    1. Zhang A., Sun H., Yan G., Wang P., Han Y., Wang X. Metabolomics in diagnosis and biomarker discovery of colorectal cancer. Cancer Letters. 2014;345(1):17–20. doi: 10.1016/j.canlet.2013.11.011. - DOI - PubMed
    1. Haviland J. A., Tonelli M., Haughey D. T., Porter W. P., Assadi-Porter F. M. Novel diagnostics of metabolic dysfunction detected in breath and plasma by selective isotope-assisted labeling. Metabolism: Clinical and Experimental. 2012;61(8):1162–1170. doi: 10.1016/j.metabol.2011.12.010. - DOI - PMC - PubMed

Publication types

LinkOut - more resources